Clinical trial NCT04510077: SmartQuit Program for Smoking Cessation
Official title: Study of SmartQuit, a Smartphone-Based Smoking Cessation Program
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: Cigarette Smoking-Related Carcinoma
Tobacco-Related Carcinoma
Lead sponsor: Fred Hutchinson Cancer Center
Sponsor class: OTHER
Collaborators: name: Life Sciences Discovery Fund
First posted: 2020-08-12
Enrollment: 99
Sex: ALL
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Allocation: NA
Intervention model: SINGLE_GROUP
Primary purpose: PREVENTION

Brief summary: This trial investigates how well a smartphone-based smoking cessation program called SmartQuit works to help patients stop smoking. SmartQuit is an smartphone application-based smoking cessation program that includes a defined program consisting of interactive evidence-based exercises for dealing more effectively with urges to smoke, a place to track desired behaviors, personalized plans for quitting, and a certificate of completion once the recommended program components are completed. SmartQuit may help patients quit smoking, lower healthcare costs and reduce premature tobacco-related deaths.

Detailed description: OUTLINE:

Patients use the SmartQuit program to learn and practice skill modules as often as they wish over 6 months.

Eligibility criteria: Inclusion Criteria:

* Smokes at least five cigarettes daily for at least past 12 months
* Wants to quit in the next 30 days
* Interested in learning skills to quit smoking
* Resides in United States (US)
* Has at least daily access to their own smartphone
* Knows how to login and download a smartphone application from their smartphone
* Willing and able to read in English
* Not participating in other smoking cessation interventions (including our other intervention studies)
* Must be an employee of a company who is participating in recruitment
* Willing to complete one follow-up survey
* Provide email, phone, and mailing address

Primary outcomes:
measure: Number of participants with 7-day cigarette smoking cessation at 2 months.
timeFrame: At 2 month follow-up
Secondary outcomes:
measure: 24-hour point prevalence quit rate
timeFrame: At 2 month follow-up
measure: Change in number of cigarettes smoked per day
timeFrame: At 2 month follow-up
measure: Number of intentional 24-hour quit attempts
timeFrame: At 2 month follow-up
measure: Change in readiness to quit
timeFrame: At 2 month follow-up
measure: Nicotine dependence level
timeFrame: At 2 month follow-up
measure: Number of times logged into the application
timeFrame: At 2 month follow-up
measure: Time spent on the application
timeFrame: At 2 month follow-up
measure: Participant satisfaction with the application
timeFrame: At 2 month follow-up
measure: Participant opinion of the usefulness of the application for quitting smoking
timeFrame: At 2 month follow-up
Other outcomes:
Locations:
city: Seattle
country: United States
facility: Fred Hutch/University of Washington Cancer Consortium
state: Washington
Study officials:
affiliation: Fred Hutch/University of Washington Cancer Consortium
name: Jonathan Bricker
role: PRINCIPAL_INVESTIGATOR
References: